ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 71 filers reported holding ATHIRA PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $925,316 | -33.2% | 458,077 | -2.5% | 0.00% | – |
| Q2 2023 | $1,385,648 | +17.0% | 469,711 | -0.8% | 0.00% | – |
| Q1 2023 | $1,184,098 | -20.4% | 473,639 | +1.0% | 0.00% | – |
| Q4 2022 | $1,487,253 | +2.4% | 469,165 | -4.1% | 0.00% | – |
| Q3 2022 | $1,453,000 | +11.3% | 489,254 | +14.2% | 0.00% | – |
| Q2 2022 | $1,306,000 | -73.0% | 428,490 | +19.4% | 0.00% | – |
| Q1 2022 | $4,843,000 | +56.3% | 358,742 | +50.8% | 0.00% | – |
| Q4 2021 | $3,099,000 | +54.9% | 237,866 | +11.6% | 0.00% | – |
| Q3 2021 | $2,001,000 | +1063.4% | 213,231 | +1173.1% | 0.00% | – |
| Q2 2021 | $172,000 | -12.7% | 16,749 | +56.3% | 0.00% | – |
| Q1 2021 | $197,000 | -94.6% | 10,713 | -90.0% | 0.00% | – |
| Q4 2020 | $3,680,000 | +1243.1% | 107,429 | +625.0% | 0.00% | – |
| Q3 2020 | $274,000 | – | 14,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |